Contact Us

Oligonucleotides are short DNA or RNA molecules and have specific sequence of nucleotide residue, which makes an entire molecule. Oligonucleotides readily bind in specific sequencing manner to their respective DNA-RNA oligonucleotide to form duplex chain. Oligonucleotides are chemically synthesized molecular chains with phosphoramidites components of natural or chemically modified nucleosides and have wide range of applications in generic testing, research, and forensic.

Global Oligonucleotide Synthesis Market - Drivers

Research institutes and diagnostic centers have shifted their focus on genomics and genetics due to their high efficiency, which has increased demand for high quality synthesized oligonucleotides in the market over the past few years. For instance, in July 2020, researchers of Rosalind Franklin University of Medicine and Science initiated a new therapeutic approach for treating Batten disease, a fatal neurodegenerative disease in children, with the help of antisense oligonucleotides. These factors are expected to drive the global oligonucleotide synthesis market growth.

Global Oligonucleotide Synthesis Market - Impact of COVID-19

The coronavirus pandemic has affected each and every market globally. There has been increasing demand for effective treatment against COVID-19. Presently, pharmaceutical companies and healthcare providers are focused on discovering more efficient use of oligonucleotides and its application to prevent the spread of COVID-19. For instance, in 2020, Innovative Genomic Institute stated that they are working on aerosolized locked nucleic acid modified antisense oligonucleotide that can be inhaled or nebulised for treatment of COVID-19 infections. Such innovations are generating an interest amongst healthcare providers and stimulating them to fight against COVID-19 pandemic. Thus, COVID-19 has affected the global oligonucleotide synthesis market in a positive way.

Global Oligonucleotide Synthesis Market - Restraints

Natural oligonucleotides are composed of ribose or deoxyribose sugar phosphate as a base, which are quickly degraded in the body by nucleus, so they are not much effective. Moreover in generic testing, oligo-degradation can affect cell growth and cause proliferation. Furthermore, low quality of microarray generated oligonucleotide sequence is a major challenge in adopting microarray technology for oligonucleotide synthesis. These factors are expected to restrain the global oligonucleotide synthesis market growth.

Global Oligonucleotide Synthesis Market - Regional Analysis

On the basis of region, the global oligonucleotide synthesis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to experience significant growth due to the presence of better pharmaceutical infrastructure and increasing use of oligonucleotides by pharmaceutical companies. Moreover, biotechnological companies are focusing on research and development in order to increase their market share in the global oligonucleotide synthesis market. For instance, in 2019, Integrated DNA Technology, a biotechnological company in the U.S., launched ‘oPools- oligo pools’, a pool of high quality DNA oligonucleotides with 350 nucleotides in length.

Moreover, Asia Pacific region comprises fast growing life science market and has greater focus on research in genetics and genomics, and its applications. Biotechnological companies are focusing on expanding their manufacturing facilities due to increasing demand for oligonucleotides from pharmaceutical companies. For instance, in March 2020, STA pharmaceuticals, a subsidiary of WuXi AppTech, announced inauguration of its large scale oligonucleotide active pharmaceutical ingredient manufacturing facility in China.

Global Oligonucleotide Synthesis Market - Competitive Landscape

Key players operating in the global oligonucleotide synthesis market include Thermo Fisher Scientific, Integrated DNA Technologies, Inc, Sigma-Aldrich Corporation, GE Healthcare, TriLink BioTechnologies, Inc, BioAutomation Corporation, Twist Bioscience, and Shanghai SynTheAll Pharmaceutical Co., Ltd.

Key Developments-

  1. In 2019, Twist Biosciences, a biotechnological company in the U.S., launched its long oligonucleotide with 300 nucleotides sequence to increase the productivity of biological research
  2. In 2018, Corden Pharma GmbH (Germany) expanded its new oversea commercial oligonucleotide active pharmaceutical ingredient manufacturing facility at CordenPharma Colorado in the U.S., which will help to grow network in Europe and U.S.

Global Oligonucleotide Synthesis Market - Taxonomy

  • By Product Type
    • Probe
    • Linkers
    • Adaptor
    • Drugs
    • Reagent
    • Equipment
  • By Application
    • Research
    • Diagnostic
    • Therapeutics
  • By End User
    • Research Institutes
    • Biotechnology Companies
    • Pharmaceutical Companies
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
N/A
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner